Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Sunday, July 14, 2024 | Back issues
Courthouse News Service Courthouse News Service

MedImmune Accused Of Stealing |Blockbuster HPV Vaccine Technology

WILMINGTON, DEL. (CN) - MedImmune's human papillomavirus virus vaccine, Cervarix, will generate $2 billion a year and MedImmune plans to stiff the nonprofit Boyce Thompson Institute for Plant Research, which supplied it with the "high five cell line" technology that made the vaccine possible, Boyce Thompson claims in New Castle Superior Court.

MedImmune, a subsidiary of AstraZeneca, stole and converted trade secrets, in breach of contract, and plans to sell the blockbuster drug with a partner, GlaxoSmithKline, says Boyce Thompson, which seeks punitive damages. See complaint.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...